Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection
- 31 December 1986
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 3, S129-S135
- https://doi.org/10.1016/s0168-8278(86)80111-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- ANTIVIRAL THERAPY IN HEPATITIS B INFECTIONBritish Medical Bulletin, 1985
- TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUSThe Lancet, 1985
- ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT OF INTERFERON IN CHRONIC HEPATITIS BThe Lancet, 1985
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type BGastroenterology, 1985
- Comparative study of DHBV DNA levels and endogenous dna polymerase activity in naturally infected ducklings in FranceJournal of Virological Methods, 1985
- Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2′-deoxyuridineAntiviral Research, 1984
- Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerasesAntimicrobial Agents and Chemotherapy, 1984
- ACYCLOVIR INHIBITS HEPATITIS B VIRUS REPLICATION IN MANThe Lancet, 1982
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981